Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Masked machete-wielding raiders stormed into a convenience store and threatened the assistant, before stealing cash, cigarettes and alcohol.
GPs have a public duty to tell authorities if a patient is driving against medical advice, new guidance from the GMC says.
The Government may be about to announce a new levy on council tax of up to 2% to replenish social care budgets.